Skip to main content
NVDA+0.72%AAPL-0.44%MSFT-0.85%GOOGL-1.06%AMZN+0.39%TSM+1.40%SPCX-0.40%META-0.23%AVGO+2.33%TSLA+1.03%LLY+0.45%BRK-B+1.17%MU+2.34%SKHY+4.09%WMT+0.33%JPM+0.74%AMD+2.80%XOM+0.73%V-0.92%JNJ+0.94%ASMLa+1.29%MA-1.62%ABBV+0.40%INTC+4.04%CVX-0.51%1398.HK+2.15%0700.HK-0.31%COST+0.18%CSCO+3.51%KO-0.01%ORCL-0.08%PG-0.68%UNH-1.77%1816.HK+1.32%BAC-0.08%3988.HK+0.66%HD-0.14%CAT+0.75%0857.HK-0.98%PM+1.20%0939.HK+0.81%AP2d+1.11%AMAT+2.74%1288.HK+0.60%GE+0.98%LRCX+3.22%DELL+2.37%0005.HK-5.56%HSBA.L-6.80%NVS+1.78%NZDMXN+0.60%USDJPY+0.58%NZDJPY+0.58%EURNZD-0.53%AUDJPY+0.52%EURUSD-0.52%AUDDKK+0.47%NZDCHF+0.47%USDCHF+0.46%CADJPY+0.46%EURAUD-0.45%GBPTRY+0.41%AUDCHF+0.41%GBPUSD-0.41%GBPNZD-0.40%EURCAD-0.37%NZDSGD+0.36%GBPAUD-0.35%EURSEK-0.34%CADCHF+0.33%GBPHKD+0.32%USDPLN+0.31%EURCNH-0.30%GBPCAD-0.29%GBPMXN-0.28%EURHKD-0.28%USDDKK+0.27%USDMXN+0.27%EURNOK-0.24%EURSGD-0.24%AUDSGD+0.23%AUDNOK+0.22%CHFSEK-0.21%USDTRY+0.18%USDILS+0.16%GBPJPY+0.16%NOKJPY+0.15%GBPSGD-0.15%USDZAR+0.14%SGDJPY+0.14%PLNJPY-0.14%USDCAD+0.13%EURZAR-0.13%CHFJPY+0.13%NZDCAD+0.12%CHFNOK-0.11%EURGBP-0.10%CHFSGD-0.10%USDSEK-0.07%AUDNZD-0.07%EURJPY+0.07%EURCHF-0.07%AUDUSD-0.06%AUDCAD+0.06%USDTHB-0.06%EURPLN+0.04%GBPZAR-0.04%GBPCHF+0.04%USDCOP-0.04%USDHKD+0.04%USDSGD+0.03%USDNOK+0.03%USDCNH-0.02%EURCZK0.00%EURDKK0.00%NZDUSD0.00%COFFEE-1.76%XPTUSD-1.59%GAGUSD-1.23%XAGUSD-1.23%HG1+1.17%SUGAR+0.92%XNGUSD+0.75%S1+0.48%UKOIL-0.41%COCOA+0.31%USOIL-0.25%W1+0.25%BTCUSD-0.14%ETHUSD+23.96%USDTUSD0.00%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT-0.15%ZECUSDT+1.60%DOGEUSD+20.65%XMRUSDT-0.52%LINKUSD+25.58%BCHUSDT+0.05%XLMUSD-0.69%UNIUSD-1.61%LTCUSD+17.89%SUIUSD-0.56%HBARUSDT-1.92%TONUSD+41.71%TAOUSDT-1.22%AAVEUSD-3.15%DOTUSDT-2.38%ICPUSDT-2.13%ONDOUSDT-1.78%WLDUSDT-0.78%ARBUSDT-1.00%JUPUSDT-1.50%INJUSDT-2.90%ATOMUSDT-1.80%STXUSDT-1.73%TIAUSDT-3.99%PYTHUSDT-3.58%FETUSDT-0.37%SEIUSDT-1.38%IMXUSDT-1.38%GRTUSDT-2.00%OPUSDT-1.09%IOTAUSDT+0.31%WIFUSDT-1.72%POLUSDT-1.83%AXSUSDT-0.90%EOSUSDT+0.58%FARTCOINUSDT+0.44%DYDXUSDT-0.42%GALAUSDT-1.91%ORDIUSDT-0.38%RONINUSDT+0.02%NOTUSDT-0.80%NVDA+0.72%AAPL-0.44%MSFT-0.85%GOOGL-1.06%AMZN+0.39%TSM+1.40%SPCX-0.40%META-0.23%AVGO+2.33%TSLA+1.03%LLY+0.45%BRK-B+1.17%MU+2.34%SKHY+4.09%WMT+0.33%JPM+0.74%AMD+2.80%XOM+0.73%V-0.92%JNJ+0.94%ASMLa+1.29%MA-1.62%ABBV+0.40%INTC+4.04%CVX-0.51%1398.HK+2.15%0700.HK-0.31%COST+0.18%CSCO+3.51%KO-0.01%ORCL-0.08%PG-0.68%UNH-1.77%1816.HK+1.32%BAC-0.08%3988.HK+0.66%HD-0.14%CAT+0.75%0857.HK-0.98%PM+1.20%0939.HK+0.81%AP2d+1.11%AMAT+2.74%1288.HK+0.60%GE+0.98%LRCX+3.22%DELL+2.37%0005.HK-5.56%HSBA.L-6.80%NVS+1.78%NZDMXN+0.60%USDJPY+0.58%NZDJPY+0.58%EURNZD-0.53%AUDJPY+0.52%EURUSD-0.52%AUDDKK+0.47%NZDCHF+0.47%USDCHF+0.46%CADJPY+0.46%EURAUD-0.45%GBPTRY+0.41%AUDCHF+0.41%GBPUSD-0.41%GBPNZD-0.40%EURCAD-0.37%NZDSGD+0.36%GBPAUD-0.35%EURSEK-0.34%CADCHF+0.33%GBPHKD+0.32%USDPLN+0.31%EURCNH-0.30%GBPCAD-0.29%GBPMXN-0.28%EURHKD-0.28%USDDKK+0.27%USDMXN+0.27%EURNOK-0.24%EURSGD-0.24%AUDSGD+0.23%AUDNOK+0.22%CHFSEK-0.21%USDTRY+0.18%USDILS+0.16%GBPJPY+0.16%NOKJPY+0.15%GBPSGD-0.15%USDZAR+0.14%SGDJPY+0.14%PLNJPY-0.14%USDCAD+0.13%EURZAR-0.13%CHFJPY+0.13%NZDCAD+0.12%CHFNOK-0.11%EURGBP-0.10%CHFSGD-0.10%USDSEK-0.07%AUDNZD-0.07%EURJPY+0.07%EURCHF-0.07%AUDUSD-0.06%AUDCAD+0.06%USDTHB-0.06%EURPLN+0.04%GBPZAR-0.04%GBPCHF+0.04%USDCOP-0.04%USDHKD+0.04%USDSGD+0.03%USDNOK+0.03%USDCNH-0.02%EURCZK0.00%EURDKK0.00%NZDUSD0.00%COFFEE-1.76%XPTUSD-1.59%GAGUSD-1.23%XAGUSD-1.23%HG1+1.17%SUGAR+0.92%XNGUSD+0.75%S1+0.48%UKOIL-0.41%COCOA+0.31%USOIL-0.25%W1+0.25%BTCUSD-0.14%ETHUSD+23.96%USDTUSD0.00%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT-0.15%ZECUSDT+1.60%DOGEUSD+20.65%XMRUSDT-0.52%LINKUSD+25.58%BCHUSDT+0.05%XLMUSD-0.69%UNIUSD-1.61%LTCUSD+17.89%SUIUSD-0.56%HBARUSDT-1.92%TONUSD+41.71%TAOUSDT-1.22%AAVEUSD-3.15%DOTUSDT-2.38%ICPUSDT-2.13%ONDOUSDT-1.78%WLDUSDT-0.78%ARBUSDT-1.00%JUPUSDT-1.50%INJUSDT-2.90%ATOMUSDT-1.80%STXUSDT-1.73%TIAUSDT-3.99%PYTHUSDT-3.58%FETUSDT-0.37%SEIUSDT-1.38%IMXUSDT-1.38%GRTUSDT-2.00%OPUSDT-1.09%IOTAUSDT+0.31%WIFUSDT-1.72%POLUSDT-1.83%AXSUSDT-0.90%EOSUSDT+0.58%FARTCOINUSDT+0.44%DYDXUSDT-0.42%GALAUSDT-1.91%ORDIUSDT-0.38%RONINUSDT+0.02%NOTUSDT-0.80%
IN

Insmed Incorporated (INSM)

NASDAQ • Healthcare

$93.33
-$0.06 (-0.1%)
Market closed

Last close at October 26, 2026 at 20:00 UTC

Open$93.44
Day Range$92.96 - $94.34
Avg. Volume (3M)3M
Market Cap$20.3B
52 Week Range
$90.39$212.75
Next EarningsIn 2 daysOct 29, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$425.4M100%
Gross Profitminus cost of goods$358.2M84%

In plain terms: out of every $100 in revenue, Insmed Incorporated currently loses $3.

Fundamentals & Financials

Revenue (TTM)
$1.1B
Net Income (TTM)
-$875.3M
EPS (TTM)
-$4.11
ROA (TTM)
-41.63%
Current Ratio
3.72

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-43.9%Q1 2026-$1.54
+21.1%Q2 2026-$0.76
+91.1%Q3 2026-$0.06
Next

Oct 29

in 2 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +91.1%

Insmed’s revenue topped consensus in the second fiscal quarter of 2026, reported on Aug. 6 based on preliminary results, as revenue rose roughly 296% to about $425.5 million from $107.4 million a year ago and exceeded the $393.7 million estimate by 8.1%. Gross profit came in at about $358.3 million, with gross margin near 84%, while operating cash flow was negative $311.6 million. Consensus for the next period calls for EPS of $-0.52 on revenue of $466.9 million.

Next report — what to expect

Insmed Incorporated (INSM) is scheduled to report earnings on October 29, 2026. With consensus figures unavailable, focus is likely to stay on management commentary and updates tied to the quarter’s performance. Historically, Insmed has beaten EPS expectations in 2 of its 8 most recent quarters.

View full earnings history

About Insmed Incorporated

Insmed Incorporated is a biotechnology company listed on the NASDAQ under INSM that develops and commercializes therapies for serious diseases, with $606.4 million in revenue in FY2025. Its business today centers on ARIKAYCE, while its research pipeline extends into rare lung disease and other neutrophil-driven disorders.

Name
Insmed Incorporated
CEO
William H. Lewis
Website
www.insmed.com
Industry
Healthcare
Year Founded
1988
Employees
1,664

Today's Snapshot

AI-generated

INSM ended the day slightly lower at 93.33, in line with a flat sector. At the close, INSM was within 3.2% of its 52-week low of 90.39. Insmed launched BRINSUPRI, a lung-disease treatment, in Japan.

Trading Volume

Above 10d avg 2.9M

3.3M

vs S&P 500 Today

Underperforming Market

-0.75%

Updated: October 26, 2026 at 20:27 UTC

Technical Indicators

2 Buy0 Neutral6 Sell
INSM is trading at 93.33 and shows a distinctly bearish technical profile: a strong ADX near 46.93 confirms robust trending pressure while momentum is weak with RSI down around 28 and MACD remaining negative. Price sits below the short, medium and 200-day moving averages, underscoring broad downside bias, and on-balance volume is deeply negative, indicating distribution. Volatility is modestly elevated, and the pivot sits close to the market without offering clear support. Technical takeaway: Strong Sell — pronounced trend strength and pervasive weakness below key averages drive the bearish stance.
All signals
  • EMA (5 indicators)$96.26 - $132.68
    Sell
  • RSI (14)28.20
    Buy
  • Stochastic %K (14, 3, 3)7.32
    Buy
  • MACD Level (12, 26)-6.14
    Sell

Peers & Related Assets

UTHRUnited Therapeutics Corporation
$592.84+0.9%
LQDALiquidia Corporation
$43.74+2.6%
TBPHTheravance Biopharma Inc
$17.030.0%
AVLNAvalyn Pharma Inc. Common Stock
PULMPulmatrix, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.